These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 26598514)
1. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials. Le Tourneau C; Kamal M; Tsimberidou AM; Bedard P; Pierron G; Callens C; Rouleau E; Vincent-Salomon A; Servant N; Alt M; Rouzier R; Paoletti X; Delattre O; Bièche I J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598514 [TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial. Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854 [TBL] [Abstract][Full Text] [Related]
3. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH. Coyne GO; Takebe N; Chen AP Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823 [TBL] [Abstract][Full Text] [Related]
4. Pediatric oncology enters an era of precision medicine. Seibel NL; Janeway K; Allen CE; Chi SN; Cho YJ; Glade Bender JL; Kim A; Laetsch TW; Irwin MS; Takebe N; Tricoli JV; Parsons DW Curr Probl Cancer; 2017; 41(3):194-200. PubMed ID: 28343740 [TBL] [Abstract][Full Text] [Related]
5. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors. Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416 [TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256 [TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in cancer. Tsimberidou AM Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154 [TBL] [Abstract][Full Text] [Related]
8. Precision medicine in pediatric oncology. Forrest SJ; Geoerger B; Janeway KA Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430 [TBL] [Abstract][Full Text] [Related]
9. Moving Molecular Profiling to Routine Clinical Practice: A Way Forward? Freidlin B; Allegra CJ; Korn EL J Natl Cancer Inst; 2020 Aug; 112(8):773-778. PubMed ID: 31868907 [TBL] [Abstract][Full Text] [Related]
10. Molecular tests and target therapies in oncology: recommendations from the Italian workshop. Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524 [TBL] [Abstract][Full Text] [Related]
11. Application of molecular profiling in clinical trials for advanced metastatic cancers. Kummar S; Williams PM; Lih CJ; Polley EC; Chen AP; Rubinstein LV; Zhao Y; Simon RM; Conley BA; Doroshow JH J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663694 [TBL] [Abstract][Full Text] [Related]
12. [Cancer: three eras of personalized medicine]. Jordan B Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388 [TBL] [Abstract][Full Text] [Related]
13. Precision medicine for managing diabetes. Klonoff DC J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409 [No Abstract] [Full Text] [Related]
14. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine. Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568 [TBL] [Abstract][Full Text] [Related]
15. A decision support framework for genomically informed investigational cancer therapy. Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335 [TBL] [Abstract][Full Text] [Related]
16. Precision oncology: current and future platforms for treatment selection. Tang X; Berger MF; Solit DB Trends Cancer; 2024 Sep; 10(9):781-791. PubMed ID: 39030146 [TBL] [Abstract][Full Text] [Related]
18. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176 [TBL] [Abstract][Full Text] [Related]
19. Personalized cancer genomics: the road map to clinical implementation. Yousef GM Clin Chem; 2012 Apr; 58(4):661-3. PubMed ID: 22322979 [No Abstract] [Full Text] [Related]
20. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review. Syn NL; Yong WP; Goh BC; Lee SC Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]